Can a dysfunctional T-cell gene signature predict nonresponse to PD-1 blockade in non-small cell lung cancer?

被引：0

作者：

Taniguchi, Hirokazu ^{[1
,2
]}

Ashizawa, Kazuto ^{[1
,3
]}

Mukae, Hiroshi ^{[2
]}

机构：

[1] Nagasaki Univ Hosp, Clin Oncol Ctr, 1-7-1 Sakamoto, Nagasaki 8528501, Japan

[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Resp Med, Nagasaki, Japan

[3] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oncol, Nagasaki, Japan

来源：

TRANSLATIONAL LUNG CANCER RESEARCH | 2024年 / 13卷 / 08期

关键词：

Immune checkpoint inhibitors (ICIs); non-small cell lung cancer (NSCLC); biomarkers; T cell; programmed cell death-1 (PD-1); NIVOLUMAB; DOCETAXEL; IMMUNOTHERAPY;

D O I：

10.21037/tlcr-24-286

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2091 / 2094

页数：4

共 19 条

[1] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[2]

Borghaei H, 2021, J CLIN ONCOL, V39, P723, DOI 10.1200/JCO.20.01605

[3] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[4] Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score=1% in the KEYNOTE-042 Study [J].

de Castro Jr, Gilberto ;

Kudaba, Iveta ;

Wu, Yi-Long ;

Lopes, Gilberto ;

Kowalski, Dariusz M. ;

Turna, Hande Z. ;

Caglevic, Christian ;

Zhang, Li ;

Karaszewska, Boguslawa ;

Laktionov, Konstantin K. ;

Srimuninnimit, Vichien ;

Bondarenko, Igor ;

Kubota, Kaoru ;

Mukherjee, Rinee ;

Lin, Jianxin ;

Souza, Fabricio ;

Mok, Tony S. K. ;

Cho, Byoung Chul .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) :1986-+

[5] A Dysfunctional T-cell Gene Signature for Predicting Nonresponse to PD-1 Blockade in Non-small Cell Lung Cancer That Is Suitable for Routine Clinical Diagnostics [J].

Hummelink, Karlijn ;

Tissier, Renaud ;

Bosch, Linda J. W. ;

Krijgsman, Oscar ;

van den Heuvel, Michel M. ;

Theelen, Willemijn S. M. E. ;

Damotte, Diane ;

Goldwasser, Francois ;

Leroy, Karen ;

Smit, Egbert F. ;

Meijer, Gerrit A. ;

Thommen, Daniela S. ;

Monkhorst, Kim .

CLINICAL CANCER RESEARCH, 2024, 30 (04) :814-823

[6] PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC [J].

Hummelink, Karlijn ;

van der Noort, Vincent ;

Muller, Mirte ;

Schouten, Robert D. ;

Lalezari, Ferry ;

Peters, Dennis ;

Theelen, Willemijn S. M. E. ;

Koelzer, Viktor H. ;

Mertz, Kirsten D. ;

Zippelius, Alfred ;

van den Heuvel, Michel M. ;

Broeks, Annegien ;

Haanen, John B. A. G. ;

Schumacher, Ton N. ;

Meijer, Gerrit A. ;

Smit, Egbert F. ;

Monkhorst, Kim ;

Thommen, Daniela S. .

CLINICAL CANCER RESEARCH, 2022, 28 (22) :4893-4906

[7] The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker [J].

Jardim, Denis L. ;

Goodman, Aaron ;

Gagliato, Debora de Melo ;

Kurzrock, Razelle .

CANCER CELL, 2021, 39 (02) :154-173

[8]

Kurose K, 2023, ADV CLIN CHEM, V112, P155, DOI 10.1016/bs.acc.2022.09.004

[9] Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance [J].

Martins, Filipe ;

Sofiya, Latifyan ;

Sykiotis, Gerasimos P. ;

Lamine, Faiza ;

Maillard, Michel ;

Fraga, Montserrat ;

Shabafrouz, Keyvan ;

Ribi, Camillo ;

Cairoli, Anne ;

Guex-Crosier, Yan ;

Kuntzer, Thierry ;

Michielin, Olivier ;

Peters, Solange ;

Coukos, Georges ;

Spertini, Francois ;

Thompson, John A. ;

Obeid, Michel .

NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (09) :563-580

[10] The cancer-immunity cycle: Indication, genotype, and immunotype [J].

Mellman, Ira ;

Chen, Daniel S. ;

Powles, Thomas ;

Turley, Shannon J. .

IMMUNITY, 2023, 56 (10) :2188-2205

← 1 2 →